Lv4
480 积分 2021-08-23 加入
New Molecules and Indications for GLP-1 Medicines
1个月前
已完结
A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity
1个月前
已完结
Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells
1个月前
已完结
Peptide Drugs: Current Status and Treatment for the Treatment of Various Diseases
2个月前
已完结
Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides
2个月前
已完结
Long-Acting and Stapled GLP-1R/GIPR/GCGR Triple Agonist for the Treatment of Obesity and Atherosclerosis
5个月前
已完结
Characterizing body composition modifying effects of a glucagon‐like peptide 1 receptor‐based agonist: A meta‐analysis
6个月前
已完结
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis
6个月前
已完结
皖公网安备34019202002308
